comparemela.com

ஜிோ சேவை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FDA Clears Smaller iRhythm Monitor with AI Arrhythmia Detection

iRhythm® Technologies Continues to Fuel Innovation in

iRhythm® Technologies Continues to Fuel Innovation in Cardiac Monitoring and Unveils Two FDA Clearances for Superior Patient Care The new Zio® monitor is designed to significantly improve patient comfort, while enhanced AI capabilities raise the bar on cardiac arrhythmia detection May 24, 2021 16:39 ET | Source: iRhythm iRhythm San Francisco, California, UNITED STATES SAN FRANCISCO, May 24, 2021 (GLOBE NEWSWIRE) iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced two new 510K clearances – one for a new and improved design of its flagship monitor and a second for updated artificial intelligence (AI) capabilities. The new Zio monitor is designed to significantly improve patient comfort while the advancements to its AI capabilities will further improve rhythm and beat diagnostic accuracy. The clearances demonstrate the company�

iRhythm Technologies President and CEO Kevin King to Retire; Michael Coyle Joins Company as President and CEO Effective January 12, 2021

iRhythm Technologies President and CEO Kevin King to Retire; Michael Coyle Joins Company as President and CEO Effective January 12, 2021 December 14, 2020 16:40 ET | Source: iRhythm iRhythm San Francisco, California, UNITED STATES SAN FRANCISCO, Dec. 14, 2020 (GLOBE NEWSWIRE) iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced that Kevin King will retire as President and CEO effective January 12, 2021. Mr. King will continue to serve on iRhythm s board of directors and as an advisor to the business. Effective the same date, Mike Coyle will join the company as President and CEO and as a member of its board of directors.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.